Patel, Parind B <br/><br/>
Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial.  [electronic resource] 

 -  Intensive care medicine  04 2020 
 - 747-755 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1432-1238 
<br/><br/><label>Standard No.: </label>10.1007/s00134-019-05913-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Analgesics, Opioid--adverse effects<br/>Constipation--chemically induced<br/>Critical Care<br/>Humans<br/>Naltrexone--analogs & derivatives<br/>Opioid-Induced Constipation<br/>Quaternary Ammonium Compounds